•
Mar 31, 2024

AN2 Therapeutics Q1 2024 Earnings Report

Total Revenue
$0
EPS
-$0.56
Previous year: -$0.79
-29.1%
Gross Profit
$0
Cash and Equivalents
$114M
Previous year: $26.7M
+327.6%
Free Cash Flow
-$17.6M
Total Assets
$121M
Previous year: $91.1M
+33.1%

AN2 Therapeutics

AN2 Therapeutics